Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Prenetics Global Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2022
FY2022
FY2023
FY2024
Revenue
65.2
12.5
13.2
21.7
30.6
Cost of revenue
38.8
8.93
9.55
12.9
15.2
Gross profit
26.3
3.6
3.62
8.83
15.4
Research and development
2.78
6.39
5.99
11.7
10.9
Operating income
-1
-56.7
-66
-51.9
-48.1
Interest expense
0.06
5.24
4.2
Pre-tax income
-3.9
-217
-226
-56.7
-57.7
Income tax
-1.94
2.57
-0.25
-0.27
-7.87
Income from continuing operations
-219
-226
-56.4
-49.8
Net income to minority interests
-0.02
-0.01
0
-2.05
-3.5
Net income
-1.94
-174
-190
-62.7
-46.3
EPS, basic
-2.25
-178.81
-37.57
-5.58
-3.71
EPS, diluted
-2.25
-178.81
-37.57
-5.58
-3.71
Balance sheet
FY2020
FY2022
FY2022
FY2023
FY2024
Cash and equivalents
14.5
35.3
147
45.7
52.3
Receivables
54.9
53.2
17.7
16.8
Inventory
6.83
4.53
3.13
6.57
Total current assets
107
242
93.7
86.1
Property, plant and equipment
13
13.1
Goodwill
3.99
3.98
33.8
29.2
37.4
Intangible assets
23.8
14.8
13.4
11.6
Total assets
149
312
254
214
Total current liabilities
58.7
57.2
39.5
36.6
Lease liabilities
3.6
3.76
0.87
3.01
Total liabilities
549
68.7
44
42.2
Shareholders' equity
-401
237
206
170
Minority interests
-0.08
6.4
3.8
0.96
Total equity
31
-401
243
210
171
Total liabilities and equity
149
312
254
214
Cash flow statement
FY2020
FY2022
FY2022
FY2023
FY2024
Net income
-1.96
-174
-190
-64.8
-49.8
Cash from operations
-2.88
13.4
14.5
-13.8
-28.9
Capital expenditures
-2.86
-8.55
-4.95
-0.35
-1.01
Cash from investing
-5.97
-22
-46.1
-83
38.5
Cash from financing
11.8
29.3
143
-4.7
-3.34
Exchange rate effect
-0.02
0.09
-0.32
0.47
0.22
Free cash flow
-5.74
4.87
9.57
-14.1
-29.9
Interest paid
0.12
-0.02
0.06
Key metrics
Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $22.97 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
50.3%
Gross profit / revenue.
Operating margin
-157.2%
Operating income / revenue.
Pre-tax margin
-188.4%
Pre-tax income / revenue.
Net margin
-151.2%
Net income / revenue.
FCF margin
-97.6%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-94.3%
Cash from operations / revenue.
Return on equity (ROE)
-24.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-19.8%
Net income / average total assets.
Return on invested capital (ROIC)
-27.3%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
35.7%
Research and development expense / revenue.
Capex / revenue
3.3%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
40.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
34.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
74.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
62.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-17.4%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-16.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
12.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.36x
Current assets / current liabilities.
Quick ratio
1.89x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.43x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$3.71
Net income per basic share, as reported (split-adjusted).
Valuation
Metric
Value
How it is calculated
Market cap
$385.4M
Share price x shares outstanding.
Enterprise value
$333.2M
Market cap + total debt - cash - short-term investments.
P/S
12.6x
Market cap / revenue.
P/B
2.26x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.17x
Market cap / tangible book value, when positive.
EV/Sales
10.9x
Enterprise value / revenue.
FCF yield
-7.8%
Free cash flow / market cap.
Earnings yield
-12.0%
Net income / market cap (the inverse of P/E).
What was Prenetics Global Ltd's revenue in fiscal 2024?
Prenetics Global Ltd reported revenue of $30.6M for fiscal 2024, 40.8% higher than the year before.
Was Prenetics Global Ltd profitable in fiscal 2024?
No. It reported a net loss of $46.3M.
How much free cash flow did Prenetics Global Ltd generate in fiscal 2024?
Cash from operations of $28.9M minus capital expenditures of $1.0M left free cash flow of -$29.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.